Catherine Mergen
PhD candidate
- Name
- C. Mergen MSc
- Telephone
- +31 71 527 4245
- c.mergen@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0003-2509-6814
Catherine Mergen is a PhD Student at the Division of Drug Delivery Technology
PhD candidate
- Science
- Leiden Academic Centre for Drug Research
- LACDR/Drug Delivery Technology
- Rousel J., Mergen C., Schoones J.W., Niemeyer-van der Kolk T., Doorn M.B.A. van, Bouwstra J.A., Smeden J. van & Rissmann R. (2024), Similar alterations of the stratum corneum ceramide profile in atopic dermatitis, psoriasis, and ichthyosis: results from a systematic review and meta-analysis, Journal of Investigative Dermatology : .
- Rousel J., Mergen C., Bergmans M.E., Bruijnincx L.J., Kam M.L. de, Klarenbeek N.B., Niemeyer-van der Kolk T., Doorn M.B.A. van, Bouwstra J.A. & Rissmann R. (2024), Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial, Journal of Lipid Research 65(8): 100591.
- Rousel J., Mergen C., Bergmans ME., Klarenbeek N.B., Kolk T.N. der, Doorn M.B.A. van, Bouwstra J.A. & Rissmann R. (2024), Lesional Psoriasis is associated with alterations in the Stratum Corneum Ceramide profile and Concomitant decreases in Barrier Function, Experimental Dermatology 33(10): e15185.